RhumbLine Advisers’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$50M Buy
765,508
+10,502
+1% +$710K 0.04% 361
2026
Q2
$48.3M Sell
755,006
-8,132
-1% -$535K 0.04% 401
2026
Q1
$54.3M Buy
763,138
+3,111
+0.4% +$245K 0.05% 326
2025
Q4
$62.3M Sell
760,027
-19,094
-2% -$1.49M 0.05% 293
2025
Q3
$58.5M Sell
779,121
-10,055
-1% -$750K 0.05% 318
2025
Q2
$58.5M Sell
789,176
-5,097
-0.6% -$355K 0.05% 306
2025
Q1
$64.1M Buy
794,273
+40,391
+5% +$3.47M 0.06% 272
2024
Q4
$58.9M Buy
753,882
+29,092
+4% +$2.47M 0.05% 291
2024
Q3
$68M Sell
724,790
-77,364
-10% -$6.49M 0.06% 265
2024
Q2
$62.5M Buy
802,154
+34,307
+4% +$2.8M 0.06% 271
2024
Q1
$69.8M Buy
767,847
+29,770
+4% +$2.48M 0.07% 253
2023
Q4
$57.1M Sell
738,077
-3,527
-0.5% -$247K 0.06% 283
2023
Q3
$50.5M Buy
741,604
+73,074
+11% +$5.32M 0.06% 282
2023
Q2
$54.3M Buy
668,530
+35,113
+6% +$2.8M 0.06% 284
2023
Q1
$52M Buy
633,417
+55,977
+10% +$4M 0.06% 278

Other funds holding GEHC

RhumbLine Advisers's GEHC Position: Q3 2026 in Review

RhumbLine Advisers increased its GE HealthCare (GEHC) stake by 1.4% in Q3 2026, buying an estimated $710K and bringing the position to 765,508 shares worth $50M. The position accounts for 0.04% of the portfolio, ranked #361.

RhumbLine Advisers first reported a position in GEHC in Q1 2023 and has held it in 15 quarters since. The position peaked at $69.8M in Q1 2024. 1,225 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

  • RhumbLine Advisers held 765,508 shares of GE HealthCare worth $50M as of Q3 2026.
  • RhumbLine Advisers bought 10,502 GE HealthCare shares in Q3 2026, an estimated $710K.
  • GE HealthCare made up 0.04% of RhumbLine Advisers's portfolio in Q3 2026, its #361 holding.
  • RhumbLine Advisers first reported a position in GE HealthCare in Q1 2023 and has held it in 15 quarters since.
  • RhumbLine Advisers's GE HealthCare position peaked at $69.8M in Q1 2024.
  • 1,225 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.